Gregory N. Dietsch
Directeur Technique/Scientifique/R&D chez VentiRx Pharmaceuticals, Inc.
Provenance du réseau au premier degré de Gregory N. Dietsch
Entité | Type d'entité | Industrie | |
---|---|---|---|
VentiRx Pharmaceuticals, Inc.
VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
American Board of Toxicology
2
| Non-Profit Organization | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Gregory N. Dietsch via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
PONIARD PHARMACEUTICALS, INC. | Biotechnology | General Counsel | |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Pharmaceuticals: Other | Corporate Officer/Principal Director of Finance/CFO | |
Panomics LLC
Panomics LLC Miscellaneous Commercial ServicesCommercial Services Panomics LLC provides life sciences research reagents. It develops products and technologies for Parallel Quantitative Biology, a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. The company was founded in 2000 and is headquartered in Fremont, CA. | Miscellaneous Commercial Services | Director/Board Member | |
CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
Cerexa, Inc.
Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Director/Board Member | |
Adheron Therapeutics, Inc.
Adheron Therapeutics, Inc. BiotechnologyHealth Technology Adheron Therapeutics, Inc. discovers and develops therapeutic drugs. The firm offers Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin fibrosis. The company was founded by David Lee, Michael B. Brenner, and David L. Castaldi in 2006 and is headquartered in Berkeley, CA. | Biotechnology | Director/Board Member | |
Calistoga Pharmaceuticals, Inc.
Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Marcadia Biotech, Inc.
Marcadia Biotech, Inc. Pharmaceuticals: MajorHealth Technology Marcadia Biotech, Inc. develops therapeutic products for diabetes and obesity. It is a biopharmaceutical company focuses on developing a broad portfolio of drug candidates for treatment of diabetes and obesity. The company was founded in 2005 and is headquartered in Carmel, IN. | Pharmaceuticals: Major | Director/Board Member | |
PreCision Dermatology, Inc.
PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology PreCision Dermatology, Inc. developed skincare therapies. It offered pharmaceutical products for skin barrier restoration, dermatoses, rosacea, acne, seborrheic dermatitis, and scaling associated with hyperkeratotic skin. The company was founded by Jeffrey M. Nugent in 2010 and was headquartered in Cumberland, RI. | Pharmaceuticals: Major | Director/Board Member | |
Calibrium LLC
Calibrium LLC Pharmaceuticals: MajorHealth Technology Calibrium LLC develops biopharmaceuticals and diabetic drugs. The company is a biotech company that develops novel peptides that helps in the treatment of diabetes and related metabolic diseases. The company was founded by Fritz French and Richard DiMarch in 2013 and is headquartered in Carmel, IN. | Pharmaceuticals: Major | Director/Board Member | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
MedPointe, Inc.
MedPointe, Inc. Pharmaceuticals: MajorHealth Technology MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ. | Pharmaceuticals: Major | Director/Board Member | |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Kansas State University | College/University | Doctorate Degree | |
University of Wisconsin | College/University | Doctorate Degree | |
University of Cincinnati (Ohio) | College/University | Doctorate Degree | |
The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree | |
Washington State University | College/University | Undergraduate Degree | |
Society for Risk Analysis | Corporate Officer/Principal | ||
Academy of Toxicological Sciences | Corporate Officer/Principal | ||
Amunix, Inc.
Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
Moximed, Inc.
Moximed, Inc. Medical SpecialtiesHealth Technology Moximed, Inc. develops minimally invasive, joint sparing solutions for patients with knee osteoarthritis. Its Osteoarthritis treatment can minimize joint pain, restore normal activity levels, and slow down disease progression. The company was founded by Anton G. Clifford in 2006 and is headquartered in Hayward, CA. | Medical Specialties | Director/Board Member | |
United States Environmental Protection Agency | General Government | Corporate Officer/Principal | |
Toxicology Excellence for Risk Assessment
Toxicology Excellence for Risk Assessment Miscellaneous Commercial ServicesCommercial Services Toxicology Excellence for Risk Assessment provides human health scientific research and development services. It provides risk managers, legislators, and ordinary citizens with the toxicology information they need to make important decisions about chemical safety. The company was founded in 1995 by Michael L. Dourson and is headquartered in Cincinnati, OH. | Miscellaneous Commercial Services | Founder | |
G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Director/Board Member | |
CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Director/Board Member | |
IMAGO BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
VAXCYTE, INC. | Biotechnology | Director/Board Member | |
TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
ITERUM THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Zavante Therapeutics, Inc.
Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zavante Therapeutics, Inc. manufactures pharmaceutical products. Its product ZOLYD is an investigational, first-in-class epoxide antibiotic with a spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. The company was founded by Cam L. Garner, Evelyn Ellis-Grosse and Theodore R. Schroeder in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Scout Bio, Inc.
Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
PASSAGE BIO, INC. | Biotechnology | Director/Board Member | |
Recida Therapeutics, Inc.
Recida Therapeutics, Inc. BiotechnologyHealth Technology Recida Therapeutics, Inc. engages in the development of novel therapeutics. The company was founded by Yigong Ge, Aditya Kohli, and David A. Socks in 2016 and is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member | |
MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman |
Statistiques
Internationale
Etats-Unis | 48 |
Canada | 2 |
Australie | 2 |
Irlande | 2 |
Sectorielle
Health Technology | 35 |
Consumer Services | 7 |
Commercial Services | 5 |
Health Services | 3 |
Electronic Technology | 2 |
Opérationnelle
Director/Board Member | 88 |
Chairman | 23 |
Independent Dir/Board Member | 23 |
Corporate Officer/Principal | 16 |
Undergraduate Degree | 6 |
Relations les plus connectées
Insiders | |
---|---|
Steven Gillis | 58 |
Patrick Heron | 42 |
Ron Laufer | 13 |
Kent Snyder | 7 |
Michael L. Dourson | 6 |
Tom Swallow | 6 |
Tressa D. Randall | 4 |
Anthony L. Kiorpes | 3 |
- Bourse
- Insiders
- Gregory N. Dietsch
- Connexions Sociétés